Clinical Trial Update: Myocardial Protection With Phosphocreatine in High-RIsk Cardiac SurgEry Patients [Phase 3]

View source ↗

Summary

Phase 3 trial completion evaluating phosphocreatine for myocardial protection in high-risk cardiac surgery patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Surgery Related Conditions
• Heart Disease

Snippet

Sponsor: Meshalkin Research Institute of Pathology of Circulation | Conditions: Cardiac Surgical Procedures, Heart Valve Prosthesis Implantation | Phase 3 | Status: COMPLETED